Tratamiento hipolipemiante en la era COVID-19

BACKGROUND AND OBJECTIVES: The COVID-19 pandemic has shown that cardiovascular diseases carry a higher risk of mortality. Doubts have been raised regarding lipid therapy in these patients. The objectives are to analyze the efficacy and safety of lipid lowering therapy in patients with COVID-19. MATE...

Descripción completa

Detalles Bibliográficos
Autores principales: Frías Vargas, M., Díaz Rodríguez, A., Díaz Fernández, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Published by Elsevier España, S.L.U. 2020
Materias:
Revisión
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328617/
https://www.ncbi.nlm.nih.gov/pubmed/32718781
http://dx.doi.org/10.1016/j.semerg.2020.06.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328617/
https://www.ncbi.nlm.nih.gov/pubmed/32718781
http://dx.doi.org/10.1016/j.semerg.2020.06.014

Ejemplares similares